Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
58.00
-1.59 (-2.67%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Belite Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1,8541,9481,263750--
Market Cap Growth
54.32%54.32%68.44%---
Enterprise Value
1,7091,8611,221701--
Last Close Price
58.2363.1045.7530.14--
PB Ratio
12.7113.3613.9618.06--
P/TBV Ratio
12.7213.3713.9618.06--
Debt / Equity Ratio
0.000.000.010.02--
Quick Ratio
24.0924.0924.5020.0110.6126.36
Current Ratio
24.3124.3124.7620.3510.6626.41
Return on Equity (ROE)
-30.60%-30.60%-47.95%-43.45%-46.60%-
Return on Assets (ROA)
-20.26%-20.26%-28.50%-25.59%-27.78%-
Return on Capital (ROIC)
-21.04%-21.04%-29.61%-27.13%-29.52%-
Earnings Yield
-1.95%-1.85%-2.50%-1.69%--
FCF Yield
-1.58%-1.51%-2.37%-1.58%--
Buyback Yield / Dilution
-14.83%-14.83%-33.12%-108.74%-8.87%-
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q